Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression: a neglected major illness

P E Greenberg1, L E Stiglin, S N Finkelstein

  • 1Analysis Group, Inc., Cambridge, MA 02138.

The Journal of Clinical Psychiatry
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease-based modeling to predict fluid response in intensive care units.

Methods of information in medicine·2013
Same author

Reducing unnecessary lab testing in the ICU with artificial intelligence.

International journal of medical informatics·2013
Same author

Cost of depression: current assessment and future directions.

Expert review of pharmacoeconomics & outcomes research·2009
Same author

The risks and costs of multiple-generic substitution of topiramate.

Neurology·2009
Same author

Comparing SSRI treatment costs for depression using retrospective claims data: the role of nonrandom selection and skewed data.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same author

Performance decrements resulting from illness in the workplace: the effect of headaches.

Journal of occupational and environmental medicine·2005
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Depression significantly impacts society, costing $44 billion annually and affecting millions. Despite its burden, it

Area of Science:

  • Public Health
  • Epidemiology
  • Mental Health Research

Background:

  • Depression imposes an estimated annual cost of $44 billion.
  • Nearly 11 million individuals are affected by depression each year.
  • This study investigates why depression is often underestimated as a major illness.

Purpose of the Study:

  • To compare depression with other major illnesses like heart disease, cancer, and AIDS.
  • To highlight key characteristics of depression in relation to other diseases.
  • To understand the societal perception and classification of depression as a major illness.

Main Methods:

  • Developed a comparative illness framework.
  • Analyzed costs, prevalence, distribution, mortality, recognition, and treatability.

Related Experiment Videos

  • Compared depression against coronary heart disease, cancer, and AIDS.

    • Main Results:

    • Depression's costs accrue over longer periods due to delayed recognition and early onset.
    • The illness impacts employers through significant workplace costs.
    • Depression's subtle and prolonged nature contributes to its underestimation.

    Conclusions:

    • Increased efforts to identify and treat untreated depression are crucial due to successful treatment options.
    • Employers have a vested interest in investing in depression recognition and treatment to mitigate costs.
    • Addressing depression is warranted for societal and economic well-being.